Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.79 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.79 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | USP2 | O75604 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | HPGD | P15428 | 3/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.37 |
| ▸ | RAD51 | Q06609 | 3/20 | 0.37 |
| ▸ | P2RY6 | Q15077 | 2/20 | 0.37 |
| ▸ | LTA | P01374 | 2/20 | 0.37 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.37 |
| ▸ | RAD1 | O60671 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29454984 | 1.00 | CYP3A4 (0.79) | CYP3A4TRPA1ALDH1A1LMNATDP1 | |
| SCHEMBL6907530 | 0.93 | CYP3A4 (0.79) | CYP3A4TRPA1ALDH1A1LMNATDP1 | |
| Toluene Diisocyanate SCHEMBL28174227 | 0.89 | CYP3A4 (1.00) | CYP3A4TRPA1ALDH1A1LMNATDP1 | |
| Toluene Diisocyanate SCHEMBL29350148 | 0.89 | CYP3A4 (1.00) | CYP3A4TRPA1ALDH1A1LMNATDP1 | |
| Toluene Diisocyanate SCHEMBL19733056 | 0.89 | CYP3A4 (1.00) | CYP3A4TRPA1ALDH1A1LMNATDP1 | |
| SCHEMBL484205 | 0.89 | CYP3A4 (0.60) | CYP3A4TRPA1ALDH1A1LMNATDP1 | |
| Toluene Diisocyanate SCHEMBL29737260 | 0.89 | CYP3A4 (1.00) | CYP3A4TRPA1ALDH1A1LMNATDP1 | |
| SCHEMBL29463953 | 0.89 | CYP3A4 (0.60) | CYP3A4TRPA1ALDH1A1LMNATDP1 | |
| Toluene Diisocyanate SCHEMBL15384 | 0.89 | CYP3A4 (1.00) | CYP3A4TRPA1ALDH1A1LMNATDP1 | |
| Toluene Diisocyanate SCHEMBL6219230 | 0.87 | CYP3A4 (0.96) | CYP3A4TRPA1ALDH1A1LMNATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 709 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0216272-B1 | IMMOBILIZATION OF BIOCATALYSTS ON GRANULAR DIATOMACEOUS EARTH | HAARMANN & REIMER CORP. (US) | 1993-05-26 | — | — | EP | claimed |
| EP-0234415-B1 | METHOD FOR THE PREPARATION OF AN ENZYME-CONTAINING CELL IMMOBILIZED CONJUGATE AND THE IMMOBILIZED CONJUGATE PRODUCED THEREBY | HAARMANN & REIMER CORP. (US) | 1991-07-10 | — | — | EP | claimed |
| US-4757008-A | Enzyme immobilization in a macroporous non-ionic resin | MILES INC. (US) | 1988-07-12 | — | — | US | claimed |
| US-4713333-A | Immobilization of biocatalysts on granular diatomaceous earth | MILES LABORATORIES, INC. (US) | 1987-12-15 | — | — | US | claimed |
| EP-0234415-A2 | Method for the preparation of an enzyme-containing cell immobilized conjugate and the immobilized conjugate produced thereby | HAARMANN & REIMER CORP. (US) | 1987-09-02 | — | — | EP | claimed |
| EP-0230649-A1 | Immobilization of phenylaline ammonia-lyase | MILES INC. (US) | 1987-08-05 | — | — | EP | claimed |
| EP-0216272-A2 | Immobilization of biocatalysts on granular diatomaceous earth | HAARMANN & REIMER CORP. (US) | 1987-04-01 | — | — | EP | claimed |
| EP-0104571-A2 | Immobilization of biocatalysts on granular carbon | MILES INC. (US) | 1984-04-04 | — | — | EP | claimed |
| US-4438196-A | POLYAMINES | MILES LABORATORIES, INC. (US) | 1984-03-20 | — | — | US | claimed |
| US-3950222-A | DIISOCYANATES | AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY (JA) | 1976-04-13 | — | — | US | claimed |
| US-20260146189-A1 | ADHESIVE COMPOSITION, THE PREPARATION METHOD AND USE THEREOF | COVESTRO DEUTSCHLAND AG (DE) | 2026-05-28 | — | — | US | disclosed |
| EP-4748866-A1 | AQUEOUS POLYURETHANE DISPERSIONS AND APPLICATIONS THEREOF | Covestro Deutschland AG (DE) | 2026-05-27 | — | — | EP | disclosed |
| EP-3983466-B1 | AQUEOUS POLYURETHANE DISPERSION | COVESTRO DEUTSCHLAND AG (DE) | 2026-02-18 | — | — | EP | disclosed |
| US-20250352663-A1 | Nanoclusters Functionalized with Adenosine Triphosphate or an Analogue and Their Use | UNIV LELAND STANFORD JUNIOR (US) | 2025-11-20 | — | — | US | disclosed |
| EP-4396248-B1 | AQUEOUS POLYURETHANE-UREA DISPERSION | COVESTRO DEUTSCHLAND AG (DE) | 2025-08-06 | — | — | EP | disclosed |
| US-4053590-A | BLOOD SUBSTITUTE, PLASMA EXPANDER | ALZA CORPORATION (US) | 1977-10-11 | — | — | US | disclosed |
| US-4041208-A | ENERGY ABSORBERS, LAMINATED GLASS SHEETS USEFUL AS AUTOMOBILE WINDSHIELDS | PPG INDUSTRIES, INC. (US) | 1977-08-09 | — | — | US | disclosed |
| US-4001200-A | BLOOD SUBSTITUTE FOR CARRYING OXYGEN | ALZA CORPORATION (US) | 1977-01-04 | — | — | US | disclosed |
| US-4001401-A | BLOOD SUBSTITUTE AND BLOOD PLASMA EXPANDER COMPRISING POLYHEMOGLOBIN | ALZA CORPORATION (US) | 1977-01-04 | — | — | US | disclosed |
| US-3950222-A | DIISOCYANATES | AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY (JA) | 1976-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260146189-A1 | ADHESIVE COMPOSITION, THE PREPARATION METHOD AND USE THEREOF | PUF60, XRCC6, F7 | CYP3A4 3864/4885TRPA1 2530/4885ALDH1A1 780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.